New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc.
New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc.
复制标题
DOI:
10.1038/cddis.2011.57
复制
发表时间:
2011-06-23
影响因子:
9
通讯作者:
中科院分区:
文献类型:
--
作者:
The molecular determinants of Alzheimer's (AD) disease are still not completely known; however, in the past two decades, a large body of evidence has indicated that an important contributing factor for the disease is the development of an unbalanced homeostasis of two signaling cations: calcium (Ca2+) and zinc (Zn2+). Both ions serve a critical role in the physiological functioning of the central nervous system, but their brain deregulation promotes amyloid-β dysmetabolism as well as tau phosphorylation. AD is also characterized by an altered glutamatergic activation, and glutamate can promote both Ca2+ and Zn2+ dyshomeostasis. The two cations can operate synergistically to promote the generation of free radicals that further intracellular Ca2+ and Zn2+ rises and set the stage for a self-perpetuating harmful loop. These phenomena can be the initial steps in the pathogenic cascade leading to AD, therefore, therapeutic interventions aiming at preventing Ca2+ and Zn2+ dyshomeostasis may offer a great opportunity for disease-modifying strategies.
登录
查看更多内容
影响因子:
56.9
作者:
BUSH, AI;PETTINGELL, WH;TANZI, RE
通讯作者:
TANZI, RE
影响因子:
4.8
作者:
De Felice, Fernanda G.;Velasco, Pauline T.;Klein, William L.
通讯作者:
Klein, William L.
DOI:
10.1073/pnas.0702669104
发表时间:
2007-08-14
影响因子:
11.1
作者:
Dong, Jijun;Canfield, Jeffrey M.;Lynn, David G.
通讯作者:
Lynn, David G.
影响因子:
9
作者:
通讯作者:
--
DOI:
10.1073/pnas.90.2.567
发表时间:
1993-01-15
影响因子:
11.1
作者:
ARISPE, N;ROJAS, E;POLLARD, HB
通讯作者:
POLLARD, HB